Cutter Capital Management, LP has filed its 13F form on May 15, 2025 for Q1 2025 where it was disclosed a total value porftolio of $230 Billion distributed in 21 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Bristol Myers Squibb CO with a value of $18B, Amgen Inc with a value of $15.6B, Biogen Inc. with a value of $15.5B, Eli Lilly & CO with a value of $14.9B, and Insmed Inc with a value of $14.2B.

Examining the 13F form we can see an decrease of $14.4B in the current position value, from $244B to 230B.

Cutter Capital Management, LP is based out at New York, NY

Below you can find more details about Cutter Capital Management, LP portfolio as well as his latest detailed transactions.

Portfolio value $230 Billion
Healthcare: $225 Billion

Stock Holdings Table Market Cap. of $10 Billions to $200 Billions

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History

Summary

  • Portfolio
  • No. of Stocks 21
  • Current Value $230 Billion
  • Prior Value $244 Billion
  • Filing
  • Period Q1 2025
  • Filing Date May 15, 2025
  • Form Type 13F-HR
  • Activity in Q1 2025
  • New Purchases 10 stocks
  • Additional Purchases 5 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 6 stocks
Track This Portfolio

Track Cutter Capital Management, LP Portfolio

Follow Cutter Capital Management, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cutter Capital Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Cutter Capital Management, LP with notifications on news.